Skip to main content
HairCited

Modified platelet rich plasma therapy for alopecia totalis.

Avita Dhiman, Manmohan Bagri
Case Report Journal of cutaneous and aesthetic surgery 2024
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D38800816'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Case Reports
Stichprobengröße
1
Population
Single patient with alopecia totalis
Intervention
Modified platelet rich plasma therapy for alopecia totalis. PRP + intralesional triamcinolone acetonide
Vergleichsgruppe
None
Primärer Endpunkt
Hair regrowth in alopecia totalis
Wirkungsrichtung
Positive
Verzerrungsrisiko
High

Abstract

Alopecia areata (AA) is an autoimmune disease characterized most commonly by patchy nonscarring hair loss which may progress to alopecia totalis which has poor prognosis. Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide that is modified PRP proved to be beneficial in the case of alopecia totalis and helps in weaning patient off oral immunosuppression.

Zusammenfassung

Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide that is modified PRP proved to be beneficial in the case of alopecia totalis and helps in weaning patient off oral immunosuppression.

Used In Evidence Reviews

Similar Papers